Johns Hopkins researchers say a survey of U.S. adults shows people want much more transparency from FDA.
After retiring from FDA last year, controversial former CDER Office of Cardiology, Hematology, Endocrinology, and Nephrology director Ellis Unger join...
FDA releases its proposed rule to change the Quality System Regulation by incorporating an international standard.
The CDER Office of Prescription Drug Promotion warns CytoDyn that a video misbranded its investigational drug leronlimab by making promotional claims ...
FDA warns Toxikon/Labcorp Bedford about violations of Good Laboratory Practice regulations in a clinical study.
FDA says the BASE10 Genetics recall of a sample collection kit is Class 1.
The Natural Products Association asks FDA to determine that CBD is recognized as a dietary ingredient.